Antiaging Quantum Living (AAQL) EBITDA Margin (2019 - 2025)

Antiaging Quantum Living's EBITDA Margin history runs 7 years deep, the most recent figure standing at 73.18% for Q4 2025.

• In Q4 2025, EBITDA Margin fell 595.0% year-over-year to 73.18%; the TTM figure through Dec 2025 stood at 48.79% (up 10050.0% YoY), while the FY2025 annual figure was 87.65%, up 538459.0% from the prior year.
• EBITDA Margin came in at 73.18% for Q4 2025 at Antiaging Quantum Living, down from 16.5% in the prior quarter.
• In the past five years, EBITDA Margin ranged from a high of 16.5% in Q3 2025 to a low of 2477.25% in Q2 2023.
• A 5-year average of 543.42% and a median of 169.3% in 2022 frame the typical range for EBITDA Margin.
• Across the five-year window, EBITDA Margin soared 481325 bps in 2021 and sank 159788 bps in 2023, its largest moves.
• Antiaging Quantum Living's EBITDA Margin stood at 1379.29% in 2021, then soared by 88 bps to 169.3% in 2022, then sank by 817 bps to 1553.09% in 2023, then surged by 96 bps to 67.23% in 2024, then declined by 9 bps to 73.18% in 2025.
• According to Business Quant data, EBITDA Margin over the past three periods registered 73.18%, 16.5%, and 48.49% for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison